Eckhardt, Christine
Krismer, Florian http://orcid.org/0000-0002-4493-5073
Donnemiller, Eveline
Eschlböck, Sabine
Fanciulli, Alessandra
Raccagni, Cecilia
Bösch, Sylvia
Mair, Katherina
Scherfler, Christoph
Djamshidian, Atbin
Uprimny, Christian
Metzler, Bernhard
Seppi, Klaus
Poewe, Werner
Kiechl, Stefan
Virgolini, Irene
Wenning, Gregor K.
Funding for this research was provided by:
Austrian Science Fund (FWF KLI 380 Programm Klinische Forschung (KLIF).)
University of Innsbruck and Medical University of Innsbruck
Article History
Received: 23 August 2021
Accepted: 20 January 2022
First Online: 11 February 2022
Declarations
:
: Christine Kaindlstorfer: nothing to report. Florian Krismer: reports consultancies from the Institut de Recherches Internationales Servier, Clarion Healthcare, LLC, and grants of the MSA Coalition outside the submitted work. Eveline Donnemiller: nothing to report. Sabine Eschlböck: nothing to report. Alessandra Fanciulli: reports royalties from Springer Nature Publishing Group and Thieme Verlag, speaker fees and honoraria from International Parkinson Disease and Movement Disorders Society, IOS Press, Impact Medicom, Abbvie and Theravance Biopharma, and research grants from the Stichting ParkinsonFond, MSA Coalition, Dr Johannes Tuba Stiftung and the Österreichischer Austausch Dienst, outside of the submitted work. Cecilia Raccagni: nothing to report. Sylvia Bösch: nothing to report. Katherina Mair: nothing to report. Christoph Scherfler: nothing to report. Atbin Djamshidian: nothing to report. Christian Uprimny: nothing to report. Bernhard Metzler: nothing to report. Klaus Seppi: reports personal fees from Teva, UCB, Lundbeck, AOP Orphan Pharmaceuticals AG, Roche, Grünenthal, and Abbvie; honoraria from the International Parkinson and Movement Disorders Society; research grants from the FWF Austrian Science Fund, Michael J. Fox Foundation, and International Parkinson and Movement Disorder Society, outside the submitted work. Werner Poewe: nothing to report. Stefan Kiechl: reports support from the Austrian Research Promotion Agency FFG outside the submitted work. Irene Virgolini: nothing to report. Gregor Wenning: reports consultancy and lecture fees from AbbVie, Affiris, AstraZeneca, Biogen, Lundbeck, Merz, Novartis, Ono, Teva, and Theravance, and research grants from the FWF Austrian Science Fund, the Austrian National Bank, the US MSA-Coalition, Parkinson Fonds Austria, and International Parkinson and Movement Disorder Society outside the submitted work. The authors have no conflicts of interest to declare that are relevant to the content of this article.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Medical University of Innsbruck (AN4687 311/4.25 [4307a]).
: All patients signed the informed consent regarding study participation and publishing their data (anonymously) before inclusion in the study.